Sensus Healthcare, Inc.
SRTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.81 | 0.01 | -0.18 |
| FCF Yield | -0.98% | -6.19% | -1.28% | -0.35% |
| EV / EBITDA | 10.73 | 202.62 | 6.37 | 22.11 |
| Quality | ||||
| ROIC | 10.55% | -0.57% | 26.10% | 15.55% |
| Gross Margin | 58.44% | 57.61% | 66.53% | 62.82% |
| Cash Conversion Ratio | -0.13 | -4.42 | -0.06 | -0.07 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.08% | -3.36% | 66.91% | -0.27% |
| Free Cash Flow Growth | 53.37% | -51.11% | -279.47% | 47.77% |
| Safety | ||||
| Net Debt / EBITDA | -2.52 | -283.10 | -1.60 | -3.02 |
| Interest Coverage | 0.00 | 0.00 | 7,415.50 | 4,120.00 |
| Efficiency | ||||
| Inventory Turnover | 1.72 | 0.87 | 4.26 | 5.72 |
| Cash Conversion Cycle | 283.30 | 479.15 | 92.32 | 80.26 |